CONSUN PHARMAC.GR.HD -10 (C1P) — Net Asset Momentum
CONSUN PHARMAC.GR.HD -10 (C1P) recorded a net asset momentum of 10.1% as of December 2025, with net assets of €4.84 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See CONSUN PHARMAC.GR.HD -10 (C1P) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
CONSUN PHARMAC.GR.HD -10 Net Asset Momentum (2021–2025)
This chart tracks CONSUN PHARMAC.GR.HD -10's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +10.1%, with net assets of €4.84 Billion EUR as of December 2025. Read CONSUN PHARMAC.GR.HD -10 balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for CONSUN PHARMAC.GR.HD -10 (2021–2025)
The table below shows the complete annual net asset history for CONSUN PHARMAC.GR.HD -10 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see CONSUN PHARMAC.GR.HD -10 (C1P) total market value.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €4.84 Billion | €6.41 Billion | €1.57 Billion | ▲ +10.1% |
| 2024 | €4.39 Billion | €5.85 Billion | €1.46 Billion | ▲ +12.1% |
| 2023 | €3.92 Billion | €5.51 Billion | €1.59 Billion | ▲ +13.9% |
| 2022 | €3.44 Billion | €4.89 Billion | €1.45 Billion | ▲ +18.1% |
| 2021 | €2.91 Billion | €4.36 Billion | €1.45 Billion | — |